Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Low seroprevalence and zero incidence rate of hepatitis E in men who have sex with men during a hepatitis A outbreak.

Rodríguez-Tajes S, Perpiñán E, Leonel T, Lens S, Mariño Z, Pérez-Del-Pulgar S, García-López M, Pocurull A, Koutsoudakis G, Forns X.

J Med Virol. 2019 Nov 19. doi: 10.1002/jmv.25630. [Epub ahead of print]

PMID:
31743439
2.

Hepatitis C virus intrinsic molecular determinants may contribute to the development of cholestatic hepatitis after liver transplantation.

Gambato M, Gregori J, Quer J, Koutsoudakis G, González P, Caro-Pérez N, García-Cehic D, García-González N, González-Candelas F, Esteban JI, Crespo G, Navasa M, Forns X, Pérez-Del-Pulgar S.

J Gen Virol. 2019 Jan;100(1):63-68. doi: 10.1099/jgv.0.001175. Epub 2018 Nov 19.

PMID:
30451649
3.

Torque Teno Virus Is Associated With the State of Immune Suppression Early After Liver Transplantation.

Ruiz P, Martínez-Picola M, Santana M, Muñoz J, Pérez-Del-Pulgar S, Koutsoudakis G, Sastre L, Colmenero J, Crespo G, Navasa M.

Liver Transpl. 2019 Feb;25(2):302-310. doi: 10.1002/lt.25374.

PMID:
30375165
4.

Hepatitis C virus early kinetics and resistance-associated substitution dynamics during antiviral therapy with direct-acting antivirals.

Perpiñán E, Caro-Pérez N, García-González N, Gregori J, González P, Bartres C, Soria ME, Perales C, Lens S, Mariño Z, Londoño MC, Ariza X, Koutsoudakis G, Quer J, González-Candelas F, Forns X, Pérez-Del-Pulgar S.

J Viral Hepat. 2018 Dec;25(12):1515-1525. doi: 10.1111/jvh.12986. Epub 2018 Oct 4.

PMID:
30141252
5.

Hepatitis A outbreak in Barcelona among men who have sex with men (MSM), January-June 2017: A hospital perspective.

Rodríguez-Tajes S, Perpiñán E, Caballol B, Lens S, Mariño Z, Costa J, Vilella A, Pérez-Del-Pulgar S, Forns X, Koutsoudakis G.

Liver Int. 2018 Apr;38(4):588-593. doi: 10.1111/liv.13606. Epub 2017 Nov 10.

PMID:
28980376
6.

Permissiveness of human hepatocellular carcinoma cell lines for hepatitis C virus entry and replication.

Coto-Llerena M, Koutsoudakis G, Boix L, López-Oliva JM, Caro-Pérez N, Fernández-Carrillo C, González P, Gastaminza P, Bruix J, Forns X, Pérez-Del-Pulgar S.

Virus Res. 2017 Aug 15;240:35-46. doi: 10.1016/j.virusres.2017.07.018. Epub 2017 Jul 24.

PMID:
28751105
7.

Oligonucleotide-Lipid Conjugates Forming G-Quadruplex Structures Are Potent and Pangenotypic Hepatitis C Virus Entry Inhibitors In Vitro and Ex Vivo.

Koutsoudakis G, Paris de León A, Herrera C, Dorner M, Pérez-Vilaró G, Lyonnais S, Grijalvo S, Eritja R, Meyerhans A, Mirambeau G, Díez J.

Antimicrob Agents Chemother. 2017 Apr 24;61(5). pii: e02354-16. doi: 10.1128/AAC.02354-16. Print 2017 May.

8.

Occult Hepatitis C Virus Infection: Are We Digging Too Deep?

Koutsoudakis G, Pérez-Del-Pulgar S, Forns X.

Gastroenterology. 2017 Feb;152(3):472-474. doi: 10.1053/j.gastro.2016.12.015. Epub 2016 Dec 27. No abstract available.

PMID:
28038930
9.

Hepatitis C Virus RNA Persists in Liver Explants of Most Patients Awaiting Liver Transplantation Treated With an Interferon-Free Regimen.

Gambato M, Pérez-Del-Pulgar S, Hedskog C, Svarovskia ES, Brainard D, Denning J, Curry MP, Charlton M, Caro-Pérez N, Londoño MC, Koutsoudakis G, Forns X.

Gastroenterology. 2016 Oct;151(4):633-636.e3. doi: 10.1053/j.gastro.2016.06.025. Epub 2016 Jul 1.

PMID:
27373513
10.

Pan-genotypic Hepatitis C Virus Inhibition by Natural Products Derived from the Wild Egyptian Artichoke.

Elsebai MF, Koutsoudakis G, Saludes V, Pérez-Vilaró G, Turpeinen A, Mattila S, Pirttilä AM, Fontaine-Vive F, Mehiri M, Meyerhans A, Diez J.

J Virol. 2015 Dec 9;90(4):1918-30. doi: 10.1128/JVI.02030-15. Print 2016 Feb 15.

11.

Apolipoprotein E, but Not Apolipoprotein B, Is Essential for Efficient Cell-to-Cell Transmission of Hepatitis C Virus.

Gondar V, Molina-Jiménez F, Hishiki T, García-Buey L, Koutsoudakis G, Shimotohno K, Benedicto I, Majano PL.

J Virol. 2015 Oct;89(19):9962-73. doi: 10.1128/JVI.00577-15. Epub 2015 Jul 22.

12.

Soraphen A: A broad-spectrum antiviral natural product with potent anti-hepatitis C virus activity.

Koutsoudakis G, Romero-Brey I, Berger C, Pérez-Vilaró G, Monteiro Perin P, Vondran FW, Kalesse M, Harmrolfs K, Müller R, Martinez JP, Pietschmann T, Bartenschlager R, Brönstrup M, Meyerhans A, Díez J.

J Hepatol. 2015 Oct;63(4):813-21. doi: 10.1016/j.jhep.2015.06.002. Epub 2015 Jun 10.

PMID:
26070407
13.

Analysis of serine codon conservation reveals diverse phenotypic constraints on hepatitis C virus glycoprotein evolution.

Brown RJ, Koutsoudakis G, Urbanowicz RA, Mirza D, Ginkel C, Riebesehl N, Calland N, Albecka A, Price L, Hudson N, Descamps V, Backx M, McClure CP, Duverlie G, Pecheur EI, Dubuisson J, Perez-del-Pulgar S, Forns X, Steinmann E, Tarr AW, Pietschmann T, Ball JK.

J Virol. 2014 Jan;88(1):667-78. doi: 10.1128/JVI.01745-13. Epub 2013 Oct 30.

14.

Imaging of hepatitis C virus infection in liver grafts after liver transplantation.

Mensa L, Pérez-del-Pulgar S, Crespo G, Koutsoudakis G, Fernández-Carrillo C, Coto-Llerena M, Miquel R, Allende H, Castells L, Navasa M, Forns X.

J Hepatol. 2013 Aug;59(2):271-8. doi: 10.1016/j.jhep.2013.03.023. Epub 2013 Mar 30.

PMID:
23548198
15.

[The molecular biology of hepatitis C virus].

Koutsoudakis G, Forns X, Pérez-Del-Pulgar S.

Gastroenterol Hepatol. 2013 Apr;36(4):280-93. doi: 10.1016/j.gastrohep.2012.11.005. Epub 2013 Mar 13. Review. Spanish.

PMID:
23490024
16.

A Gaussia luciferase cell-based system to assess the infection of cell culture- and serum-derived hepatitis C virus.

Koutsoudakis G, Pérez-del-Pulgar S, González P, Crespo G, Navasa M, Forns X.

PLoS One. 2012;7(12):e53254. doi: 10.1371/journal.pone.0053254. Epub 2012 Dec 31.

17.

Interplay between basic residues of hepatitis C virus glycoprotein E2 with viral receptors, neutralizing antibodies and lipoproteins.

Koutsoudakis G, Dragun J, Pérez-Del-Pulgar S, Coto-Llerena M, Mensa L, Crespo G, González P, Navasa M, Forns X.

PLoS One. 2012;7(12):e52651. doi: 10.1371/journal.pone.0052651. Epub 2012 Dec 27.

18.

Determination of IL28B polymorphisms in liver biopsies obtained after liver transplantation.

Coto-Llerena M, Crespo G, González P, Koutsoudakis G, Miquel R, Navasa M, Forns X, Pérez-del-Pulgar S.

J Hepatol. 2012 Feb;56(2):355-8. doi: 10.1016/j.jhep.2011.07.027. Epub 2011 Sep 1.

PMID:
21889467
19.

Cell culture replication of a genotype 1b hepatitis C virus isolate cloned from a patient who underwent liver transplantation.

Koutsoudakis G, Perez-del-Pulgar S, Coto-Llerena M, Gonzalez P, Dragun J, Mensa L, Crespo G, Navasa M, Forns X.

PLoS One. 2011;6(8):e23587. doi: 10.1371/journal.pone.0023587. Epub 2011 Aug 24.

20.

Production of infectious genotype 1b virus particles in cell culture and impairment by replication enhancing mutations.

Pietschmann T, Zayas M, Meuleman P, Long G, Appel N, Koutsoudakis G, Kallis S, Leroux-Roels G, Lohmann V, Bartenschlager R.

PLoS Pathog. 2009 Jun;5(6):e1000475. doi: 10.1371/journal.ppat.1000475. Epub 2009 Jun 12.

21.

Hepatitis B and C virus coinfection: a novel model system reveals the absence of direct viral interference.

Bellecave P, Gouttenoire J, Gajer M, Brass V, Koutsoudakis G, Blum HE, Bartenschlager R, Nassal M, Moradpour D.

Hepatology. 2009 Jul;50(1):46-55. doi: 10.1002/hep.22951.

PMID:
19333911
22.

CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells.

Witteveldt J, Evans MJ, Bitzegeio J, Koutsoudakis G, Owsianka AM, Angus AG, Keck ZY, Foung SK, Pietschmann T, Rice CM, Patel AH.

J Gen Virol. 2009 Jan;90(Pt 1):48-58. doi: 10.1099/vir.0.006700-0.

23.

Neutralizing host responses in hepatitis C virus infection target viral entry at postbinding steps and membrane fusion.

Haberstroh A, Schnober EK, Zeisel MB, Carolla P, Barth H, Blum HE, Cosset FL, Koutsoudakis G, Bartenschlager R, Union A, Depla E, Owsianka A, Patel AH, Schuster C, Stoll-Keller F, Doffoël M, Dreux M, Baumert TF.

Gastroenterology. 2008 Nov;135(5):1719-1728.e1. doi: 10.1053/j.gastro.2008.07.018. Epub 2008 Jul 22.

PMID:
18718838
24.

Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81.

Zeisel MB, Koutsoudakis G, Schnober EK, Haberstroh A, Blum HE, Cosset FL, Wakita T, Jaeck D, Doffoel M, Royer C, Soulier E, Schvoerer E, Schuster C, Stoll-Keller F, Bartenschlager R, Pietschmann T, Barth H, Baumert TF.

Hepatology. 2007 Dec;46(6):1722-31.

25.

Analysis of hepatitis C virus superinfection exclusion by using novel fluorochrome gene-tagged viral genomes.

Schaller T, Appel N, Koutsoudakis G, Kallis S, Lohmann V, Pietschmann T, Bartenschlager R.

J Virol. 2007 May;81(9):4591-603. Epub 2007 Feb 14. Erratum in: J Virol. 2007 Jul;81(13):7327.

26.

The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cells.

Koutsoudakis G, Herrmann E, Kallis S, Bartenschlager R, Pietschmann T.

J Virol. 2007 Jan;81(2):588-98. Epub 2006 Nov 1.

27.

Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses.

Koutsoudakis G, Kaul A, Steinmann E, Kallis S, Lohmann V, Pietschmann T, Bartenschlager R.

J Virol. 2006 Jun;80(11):5308-20.

28.

Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras.

Pietschmann T, Kaul A, Koutsoudakis G, Shavinskaya A, Kallis S, Steinmann E, Abid K, Negro F, Dreux M, Cosset FL, Bartenschlager R.

Proc Natl Acad Sci U S A. 2006 May 9;103(19):7408-13. Epub 2006 May 1.

29.

NOD2 insertion mutation in a Cretan Crohn's disease population.

Roussomoustakaki M, Koutroubakis I, Vardas EM, Dimoulios P, Kouroumalis EA, Baritaki S, Koutsoudakis G, Krambovitis E.

Gastroenterology. 2003 Jan;124(1):272-3; author reply 273-4. No abstract available.

PMID:
12512064
30.

Expression of a recombinant human anti-MUC1 scFv fragment in protease-deficient Escherichia coli mutants.

Kandilogiannaki M, Koutsoudakis G, Zafiropoulos A, Krambovitis E.

Int J Mol Med. 2001 Jun;7(6):659-64.

PMID:
11351281

Supplemental Content

Loading ...
Support Center